Heghine Khachatryan: Rethinking First-Line Therapy for Iron Deficiency Anemia in Women
Heghine Khachatryan, Editor-in-Chief at Hemostasis Today, shared a post by American Society of Hematology on LinkedIn:
“Iron deficiency anemia in women – especially those with heavy menstrual bleeding – continues to be underdiagnosed and undertreated worldwide.
New evidence published in Blood Advances and highlighted by the American Society of Hematology demonstrates that single-dose intravenous iron dextran is a cost-effective first-line therapy for this population.
When evaluated across a woman’s reproductive lifetime, IV iron provides:
- superior clinical value
- improved quality-of-life outcomes
- better long-term cost-effectiveness
compared with oral iron, which is still widely used as first-line treatment.
These findings should prompt us to reconsider current treatment algorithms and move toward more patient-centered, evidence-based care for women with iron deficiency anemia.”
Quoting American Society of Hematology’s post, adding:
“Iron deficiency anemia remains underdiagnosed and undertreated in women, particularly those with heavy menstrual bleeding.
According to new research published in Blood Advances, single-dose IV iron dextran is the cost-effective first-line therapy for this population. When evaluated across a woman’s reproductive lifetime, IV iron provided superior value and quality-of-life benefits compared with oral iron, which is currently the more predominant first-line treatment for these patients.
Learn more.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Apr 29, 2026, 01:10Are Normal-BMI Women with PCOS at Higher Risk of Adverse Obstetric and Perinatal Outcomes After FET? – RBMO
-
Apr 28, 2026, 16:13Christina Neophytou: Exceptional Learning and Conversation at the EEL Conference
-
Apr 28, 2026, 16:07Sandro Esteves: Male Infertility Work-Up, Are We Doing Enough or Too Little?
-
Apr 28, 2026, 16:04Angelos Daniilidis: Amazing Experience at the 8th European Endometriosis League Congress
-
Apr 28, 2026, 15:57Marco Zaccaria: Patient-Centred Infertility Care Takes Centre Stage at HARTUS2026
-
Apr 28, 2026, 15:46Understanding the Risks of Dilation and Curettage – Fertility Plus
-
Apr 28, 2026, 15:44Does Coffee Drinking Affect IVF Sucess? – Fertility Plus
-
Apr 28, 2026, 15:41Apply to Be an ESHRE 5 Young Ambassador – ESHRE
-
Apr 28, 2026, 15:35Szabó Gábor: Best Poster Award at the EEL Congress